Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Chantix anti-smoking pill from Pfizer coming

Chantix will be a twice-daily tablet.



May 12, 2006: Chantix, the latest anti-smoking tablet from Pfizer, has received a go-ahead from the US FDA. Chantix will be brand name for the anti-smoking drug, whose active incredient is called Varenicline.

Chantix has been in phase-III trials till now. This is the last stage before a medicine maker can put out his ware in the market. With the FDA giving approval, Pfizer hopes to put out the no-smoking, twice-daily pill Chantix in shop shelves soon.

The price of Chantix has not been revealed yet. Chantix helps prevent withdrawal symptoms and thereby reduces addiction. It also reduces the pleasure of smoking. Scientifically, Varenicline has been called a nicotine receptor partial agonist.

Currently, the non-smoking alternatives are nicotine-replacement therapies, sold by prescription like in gum, patch, lozenge, nasal spray or inhaler form. Chantix will be a tablet.

The approved course of treatment with Chantix is 12 weeks. In those patients who have quit smoking, it can be doubled to ensure they remain smoke-free.

A study on 2000 smokers treated with Chantix showed a success ratio which is higher than another no-smoking treatment called Zyban. Pfizer also submitted the results of this study to get clearance for Chantix.




Auto news for auto freaks! iDrive.in
DWS community! / Cricket blog


Latest Stories in Pharma

New Indian pharma policy almost ready
The new pharma policy for India may send drug prices crashing.

Diarrhoea drug cleared for early phase trials in India

Taal A support group by HIV infected, for HIV infected

Black women neversmokers more prone to lung cancer deaths

Cesamet cannabis drug gets OK to treat nausea

India opens new free AIDS therapy centres

Blood test to assess tobacco craving

India gets a Botox face lift

Chantix anti-smoking pill from Pfizer coming

Bangladesh pharma co Beximco plans US foray

New data shows RTA 402 potently blocks NF-kB in cancer cells through inhibition of IKK


Latest Stories in Pharma

Pharma stories archived on 7 Jan 2007

Pharma stories archived on 14 Sep, 2005




Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us